Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pathway M-1: Sphenopalatine Ganglion Stimulation for the AcuteTreatment of High Disability Migraine Headache

NCT01540799 is registered in ClinicalTrials.gov with Autonomic Technologies, Inc. as lead sponsor.

NCT NCT01540799
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01540799 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pathway M-1: Sphenopalatine Ganglion Stimulation for the AcuteTreatment of High Disability Migraine Headache
Lead sponsor
Autonomic Technologies, Inc.
Phase
Not applicable
Overall status
Completed
Start date
February 29, 2012
Completion date
May 31, 2018
Enrollment
80 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

high frequency, high disability migraine